These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33774439)

  • 1. Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data.
    Bagante F; Spolverato G; Ruzzenente A; Luchini C; Tsilimigras DI; Campagnaro T; Conci S; Corbo V; Scarpa A; Guglielmi A; Pawlik TM
    Eur J Cancer; 2021 May; 148():348-358. PubMed ID: 33774439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A naive Bayes algorithm for tissue origin diagnosis (TOD-Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system.
    Jiang W; Shen Y; Ding Y; Ye C; Zheng Y; Zhao P; Liu L; Tong Z; Zhou L; Sun S; Zhang X; Teng L; Timko MP; Fan L; Fang W
    Int J Cancer; 2018 Jan; 142(2):357-368. PubMed ID: 28921531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
    Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
    EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and disparities in the utilization of systemic chemotherapy in patients with metastatic hepato-pancreato-biliary cancers.
    Elshami M; Ahmed FA; Kakish H; Hue JJ; Hoehn RS; Rothermel LD; Bajor D; Mohamed A; Selfridge JE; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
    HPB (Oxford); 2023 Feb; 25(2):239-251. PubMed ID: 36411233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-drug conjugates for hepato-pancreato-biliary malignancies: "Magic bullets" to the rescue?
    Theocharopoulos C; Ziogas IA; Douligeris CC; Efstathiou A; Kolorizos E; Ziogas DC; Kontis E
    Cancer Treat Rev; 2024 Sep; 129():102806. PubMed ID: 39094332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
    Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
    PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of hepato-pancreato-biliary surgery during the COVID-19 pandemic: an European-African Hepato-Pancreato-Biliary Association (E-AHPBA) cross-sectional survey.
    Balakrishnan A; Lesurtel M; Siriwardena AK; Heinrich S; Serrablo A; Besselink MGH; Erkan M; Andersson B; Polak WG; Laurenzi A; Olde Damink SWM; Berrevoet F; Frigerio I; Ramia JM; Gallagher TK; Warner S; Shrikhande SV; Adam R; Smith MD; Conlon KC;
    HPB (Oxford); 2020 Aug; 22(8):1128-1134. PubMed ID: 32565039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A universal co-expression gene network and prognostic model for hepatic-biliary-pancreatic cancers identified by integrative analyses.
    Zhang J; Xiao J; Wang Y; Zheng X; Cui J; Wang C
    FEBS Open Bio; 2022 Nov; 12(11):2006-2024. PubMed ID: 36054420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A robust nine-gene prognostic signature associated with tumour doubling time for hepatocellular carcinoma.
    Huo J; Wu L; Zang Y
    Life Sci; 2020 Nov; 260():118396. PubMed ID: 32918973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approach.
    Mustea A; Ralser DJ; Egger EK; Ziehm U; Vivas S; Brock S; Jackson D; Condic M; Rauschendorf MA; Würfel P; Dombrowski F; Otten LA; Sun P; Laib A; Cordova MC; Hartmann R; Stein MA; Koensgen D; Stope MB
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):367. PubMed ID: 39052171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of genetic testing in hepatic, pancreatic, and biliary cancers.
    Hewitt DB; Aziz H; Brown ZJ; Pawlik TM
    Surg Oncol; 2022 Sep; 44():101844. PubMed ID: 36116416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.
    Li MX; Sun XM; Cheng WG; Ruan HJ; Liu K; Chen P; Xu HJ; Gao SG; Feng XS; Qi YJ
    BMC Cancer; 2021 Aug; 21(1):906. PubMed ID: 34372798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA.
    Morera DS; Hasanali SL; Belew D; Ghosh S; Klaassen Z; Jordan AR; Wang J; Terris MK; Bollag RJ; Merseburger AS; Stenzl A; Soloway MS; Lokeshwar VB
    J Urol; 2020 Jan; 203(1):62-72. PubMed ID: 31112107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer.
    Chaudhary K; Poirion OB; Lu L; Garmire LX
    Clin Cancer Res; 2018 Mar; 24(6):1248-1259. PubMed ID: 28982688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma.
    Qiao G; Li J; Huang A; Yan Z; Lau WY; Shen F
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2014-20. PubMed ID: 24989634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Benefit of Preoperative Exercise and Nutritional Therapy for Patients Undergoing Hepato-Pancreato-Biliary Surgeries for Malignancy.
    Nakajima H; Yokoyama Y; Inoue T; Nagaya M; Mizuno Y; Kadono I; Nishiwaki K; Nishida Y; Nagino M
    Ann Surg Oncol; 2019 Jan; 26(1):264-272. PubMed ID: 30367303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollment.
    Elshami M; Hue JJ; Hoehn RS; Rothermel LD; Bajor D; Mohamed A; Selfridge JE; Chavin KD; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
    HPB (Oxford); 2022 Aug; 24(8):1280-1290. PubMed ID: 35063353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing complex hepato-pancreato-biliary surgery in Uganda: Challenges and outcomes.
    Michael O; Darshit D; Mary K; Mutekoba U; Timothy M; Francis BX; Denis K; Edward K; Machyo OF; Henry D; William B; Ponsiano O
    World J Surg; 2024 Apr; 48(4):924-931. PubMed ID: 38323680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise and Nutrition Interventions for Prehabilitation in Hepato-Pancreato-Biliary Cancers: A Narrative Review.
    Christopher CN; Kang DW; Wilson RL; Gonzalo-Encabo P; Ficarra S; Heislein D; Dieli-Conwright CM
    Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma.
    Wang X; Qiao J; Wang R
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.